Executive Vice President and Chief Medical Officer · COLLEGIUM PHARMACEUTICAL, INC (COLL)

Richard Malamut

A named executive officer of COLLEGIUM PHARMACEUTICAL in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$1,761,807

Salary $422,662Stock awards $821,016

FY2019: $1,922,822

5th of 5 named executive officers at Collegium Pharmaceutical by FY2020 total.

5 named officers on file for COLLEGIUM PHARMACEUTICAL, FY2020

Richard Malamut’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 7 equity grants, each cited to its filing
  • COLL’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how COLLEGIUM PHARMACEUTICAL’s whole pay program stands against its peers

  • COLLEGIUM PHARMACEUTICAL’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on COLL→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 7, 2021 (DEF 14A).

Free

Get Richard Malamut’s full pay file as a PDF — free

More than this page: up to 10 years of Richard’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Richard Malamut compensation by year

COLLEGIUM PHARMACEUTICAL Summary Compensation Table · all 2 fiscal years held
In US dollars, as COLLEGIUM PHARMACEUTICAL reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$311,250$422,662
Bonus$0$0
Stock awards$642,600$821,016
Option awards$765,176$288,743
Non-equity incentive$186,800$211,700
Pension and deferred compensation$0$0
All other$16,996$17,686
Total$1,922,822$1,761,807

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: COLLEGIUM PHARMACEUTICAL, INC DEF 14A filed April 7, 2021, accession 0001558370-21-004046, and prior-year filings. Open the filing on EDGAR.

How this page was built: the COLLEGIUM PHARMACEUTICAL, INC filed document, accession 0001558370-21-004046. Every figure is read from that document and cited to the page and table it appears in. Filed April 7, 2021.

$1.9M
$1.8M
FY19
FY20
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU31,875$638,456—
RSU22,437$449,413—
PSU10,800$216,324—
Option22,500—$21.34
Option53,125—$15.12

Per the Outstanding Equity Awards at Fiscal Year-End table in COLLEGIUM PHARMACEUTICAL, INC's FY2020 proxy; value at the fiscal year-end close, as the company printed it.

COLLEGIUM PHARMACEUTICAL’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Joseph CiaffoniPresident and Chief Executive Officer$6,042,639
Alison FlemingExecutive Vice President and Chief Technical Officer$2,438,482
Paul BrannellyExecutive Vice President and Chief Financial Officer$2,339,087
Shirley KuhlmannExecutive Vice President and General Counsel$2,096,181
Richard Malamut · this pageExecutive Vice President and Chief Medical Officer$1,761,807

The full COLLEGIUM PHARMACEUTICAL compensation record

free company brief

This page is one person within COLLEGIUM PHARMACEUTICAL's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are COLLEGIUM PHARMACEUTICAL's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Richard Malamut's compensation dossier · One-time report. No refunds.